Flagship Ventures Fund IV General Partner LLC
CIK 1508051
13F portfolio (2016-Q2)
$585M
Positions
5
As reported on this filer's Form 13F for 2016-Q2, filed 2016-08-15. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | MCRB | SERES THERAPEUTICS INC |
| 2 | EDIT | EDITAS MEDICINE INC |
| 3 | — | SYROS PHARMACEUTICALS INC |
| 4 | — | TTOO |
| 5 | — | SESEN BIO, INC. |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →